Sotera Health (NASDAQ:SHC) Reaches New 52-Week Low – Should You Sell?

Sotera Health (NASDAQ:SHC) shares reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $10.71 and last traded at $10.73, with a volume of 609040 shares traded. The stock had previously closed at $11.50.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Barclays lowered their price objective on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research note on Friday, February 28th. The Goldman Sachs Group started coverage on Sotera Health in a research note on Friday, December 6th. They set a “neutral” rating and a $14.00 target price on the stock. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $16.00.

Sotera Health Price Performance

The stock’s fifty day moving average price is $12.73 and its 200-day moving average price is $13.89. The firm has a market cap of $3.04 billion, a price-to-earnings ratio of 42.92 and a beta of 1.92. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Blue Trust Inc. lifted its position in Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock valued at $25,000 after acquiring an additional 1,140 shares during the last quarter. Quarry LP purchased a new position in Sotera Health during the 4th quarter worth $28,000. GAMMA Investing LLC raised its holdings in Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after purchasing an additional 1,121 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock valued at $82,000 after buying an additional 1,640 shares in the last quarter. Finally, Sterling Capital Management LLC increased its holdings in shares of Sotera Health by 58.5% in the 4th quarter. Sterling Capital Management LLC now owns 9,029 shares of the company’s stock valued at $124,000 after purchasing an additional 3,331 shares in the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.